Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ante Bolanča is active.

Publication


Featured researches published by Ante Bolanča.


Breast Cancer Research and Treatment | 1994

Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen

Josip Lukač; Zvonko Kusić; Darka Kordić; Mirjana Končar; Ante Bolanča

SummaryThe number of leukocytes, proportion and absolute number of granulocytes, lymphocytes, CD4+ cells, CD8+ cells, CD16+ cells, B-lymphocytes, monocytes, natural killer cell (NK) activity, and granulocyte and monocyte phagocytic functions - ingestion and intracellular killing - were determined in a group of 27 patients with ductal invasive breast carcinoma, stage I-III, before and 7 months following postsurgical telecobalt radiotherapy, divided into two subgroups, one of them receiving tamoxifen (TMX group) and the other one not receiving any further therapy (control group). In control group, proportion of all lymphocytes and CD8+ cells as well as absolute number of all lymphocytes, CD4+, CD8+, CD16+ and B lymphocytes were decreased following TCT in comparison to their pre-TCT values, while in TMX group only absolute number of all lymphocytes remained decreased following TCT. Moreover, post-TCT proportions of all and CD8+ lymphocytes as well as absolute numbers of all and CD4+ and CD8+ lymphocytes in TMX patients were significantly increased in comparison to the same parameters in control post-TCT patients, although there was no difference between the two subgroups before TCT. At the other hand, granulocyte ingestion was decreased in post-TCT TMX patients compared to post-TCT values in control patients and NK cell activity showed a similar, although statistically not significant, tendency. It seems that TMX helps recovery of lymphocyte populations decreased by radiotherapy, probably by stimulation of cells carrying estrogen receptors, but its effects on phagocytic functions and probably NK cell activity seemed to be rather inhibitory than stimulatory.


QJM: An International Journal of Medicine | 2017

Clinical and prognostic significance of anisocytosis measured as a red cell distribution width in patients with colorectal cancer

Davor Kust; Marko Lucijanic; Kristina Urch; Ivan Šamija; Ivana Celap; Ivan Kruljac; Marin Prpić; Ivica Lucijanic; Neven Mateša; Ante Bolanča

Purpose : colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide, and detection of new prognostic markers is mandatory for patients to receive optimal oncological treatment. The aim of the study was to assess clinical and prognostic value of red cell distribution width (RDW) in patients with CRC. Methods : RDW values in 90 patients with CRC undergoing surgery for primary disease were analyzed in pre- and postoperative setting, and correlated with clinical and hematological parameters. Results : Both pre- and postoperative RDW measurements were found to be associated with features of iron deficiency anemia, inflammatory response to tumor, advanced age and depth of tumor invasion. Optimal cutoff points were calculated to be 14% for preoperative and 13.6% for postoperative RDW measurements. Elevations in both pre- and postoperative RDW values had significant effects on survival in univariate and multivariate analyses. Effects were found to be independent of tumor related features, stage of the disease, development of anemia and aberrant inflammatory response to tumor. Conclusions : RDW is an integrative parameter reflecting tumor specific features and shows significant association with overall survival in patients with CRC. This is especially important in patients with stage 2 disease where elevation in preoperative RDW values can contribute to recognition of higher risk patients.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2017

Prediction of radioactive iodine remnant ablation failure in patients with differentiated thyroid cancer: A cohort study of 740 patients.

Marin Prpić; Davor Kust; Ivan Kruljac; Lora Stanka Kirigin; Tomislav Jukić; Nina Dabelić; Ante Bolanča; Zvonko Kusić

The purpose of this study was to detect parameters that could serve as predictors of radioactive iodine (I‐131) ablation failure in patients with low‐risk and intermediate‐risk differentiated thyroid carcinoma (DTC).


Acta Clinica Croatica | 2017

Neurosifilis kod angloameričkih skladatelja i jazz glazbenika

Darko Breitenfeld; Davor Kust; Tomislav Breitenfeld; Marin Prpić; Marko Lucijanic; Davor Zibar; Vedran Hostić; Maja Franceschi; Ante Bolanča

Syphilis is a sexually transmitted, systemic disease caused by the spirochete bacterium Treponema pallidum. The most common mechanism of transmission is sexual intercourse. Although there are several hypotheses, the exact origin of the disease remains unknown. Newly published evidence suggests that the hypothesis supporting the theory of the American origin of the disease is the valid one. Among 1500 analyzed pathographies of composers and musicians, data on ten Anglo-American composers and jazz musicians having suffered from neurosyphilis (tertiary stage of the disease) were extracted for this report. In this group of Anglo-American composers and musicians, most of them died from progressive paralysis while still in the creative phase of life. Additionally, diagnoses of eleven other famous neurosyphilitic composers, as well as basic biographic data on ten less known composers that died from neurosyphilis-progressive paralysis are also briefly mentioned. In conclusion, neurosyphilis can cause serious neurological damage, as well as permanent disability or death, preventing further work and skill improvement.


Acta Clinica Croatica | 2016

Use of alternative and complementary medicine in patients with malignant diseases in high-volume cancer center and future aspects

Davor Kust; Ivan Šamija; Jasmina Marić-Brozić; Branka Svetec; Marija Miletić; Gordana Mamić; Ante Bolanča; Zvonko Kusić; Ana Frobe

Usage of complementary and alternative medicine (CAM) is steadily increasing over the last decades, gaining medical, economic and sociological importance. The aim of the present study was to assess the use of complementary and alternative therapies in cancer patients. A cross-sectional, descriptive survey design was used to collect data through an anonymous questionnaire. A total of 267 patients were included in the study. The prevalence of CAM use among cancer patients in this study was 60.3%. It was found that 61 heterogeneous CAM therapies were used, the most popular among patients being naturopathy/folk medicine. In multivariate logistic regression analysis, independent predictors of CAM use were high income, divorced status, female sex and younger age. In conclusion, considering the fact that a large proportion of patients used at least one CAM approach, we need to continue our efforts to improve the patient-oncologist communication in order to deliver most reliable information to patients and to better understand the possible standard medicine-CAM interactions. According to results of the latest studies, CAM therapies that help manage pain, nausea, fatigue, anxiety, and other symptoms should be integrated into the patient overall care.


Case Reports in Oncology | 2014

Familial adenomatous polyposis in three generations of a single family: a case study.

Jure Murgić; Iva Kirac; Zeljko Soldic; Davor Tomas; Mario Zovak; Ante Bolanča; Andrzej Plawski; Tomasz Banasiewicz; Zvonko Kusić

Background: Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited syndrome characterized by the development of numerous polyps in the colon and rectum. If left untreated, the affected patients inevitably develop colon cancer by the age of 40 years. A resection of the colon (colectomy) or of the colon and rectum (proctocolectomy) is needed to minimize the risk of cancer. Case Presentation: We report a case of FAP through three generations of a single family, in which the grandmother and granddaughter underwent total colectomy with ileoanal anastomosis and did not develop colon cancer, while the son underwent subtotal colectomy with ileorectal anastomosis and developed recurrent rectal cancer. Data regarding timely surgery, surveillance, and chemoprevention are discussed. Conclusion: The FAP phenotype determines the type of treatment. In severe polyposis, proctocolectomy with ileoanal anastomosis seems to be the optimal method for minimizing the risk of cancer development. This case report advocates complete rectal removal, especially in cases of poor patient compliance with colonoscopic surveillance.


Case Reports in Oncology | 2011

Long-time survival of a patient with metastatic pancreatic cancer: a case report.

Željko Soldić; Daniela Žitnjak; Ante Bolanča; Zvonko Kusić

Pancreatic cancer is a malignant neoplasm of the pancreas. It does not cause any symptoms in the early stage, and later symptoms are nonspecific, thus the disease is usually diagnosed when already advanced. In 2008, pancreatic cancer ranked eighth on the list of the 10 most common cancers among men in Croatia and tenth on the list of the most common cancers among Croatian women. Pancreatic cancer has a poor prognosis, with a survival time of only 6–8 months for metastatic disease. Gemcitabine is the standard chemotherapeutic option. Other chemotherapeutic agents include5-fluorouracil and leucovorin. In this paper, we present a case of a patient diagnosed with locally advanced and metastatic pancreatic cancer, who is still alive and currently receives his fourth line of chemotherapy 5 years after the diagnosis. Following disease progression on gemcitabine chemotherapy, he was treated with chemoradiotherapy which, however, had no effect. We then applied cisplatin monochemotherapy which offered excellent disease control, was well tolerated by the patient and, although somewhat obsolete in this form, showed to be a valuable chemotherapeutic option.


Anticancer Research | 2014

Hypothyroidism as a Predictive Clinical Marker of Better Treatment Response to Sunitinib Therapy

Davor Kust; Marin Prpić; Jure Murgić; Marijana Jazvić; Blanka Jakšić; Dražena Krilić; Ante Bolanča; Zvonko Kusić


Anticancer Research | 2014

Plasma Free Serotonin as a Marker for Early Detection of Breast Cancer Recurrence

Ana Frobe; Lipa Čičin-Šain; Glenn Jones; Željko Soldić; Josip Lukač; Ante Bolanča; Zvonko Kusić


Collegium Antropologicum | 2012

Dermatomyositis as Paraneoplastic Syndrome of Peritoneal and Ovarian Relapse after Long-Term Complete Remission in Patient with Metastatic Bilateral Breast Cancer

Jure Murgić; M Prpić; Iva Kirac; Adriana-Maria Camino-Varela; Ante Bolanča; Zvonko Kusić

Collaboration


Dive into the Ante Bolanča's collaboration.

Top Co-Authors

Avatar

Zvonko Kusić

Croatian Academy of Sciences and Arts

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Davor Kust

University Hospital Centre Zagreb

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Neven Mateša

University Hospital Centre Zagreb

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge